Research progress of nanomedicine in adoptive cell therapy for cancer
CSTR:
Author:
Affiliation:

Clc Number:

R730.51

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Tumor adoptive cellular immunotherapy is a new model of tumor immunotherapy. It can induce effective anti - tumor immune response in patients by infusion the engineered immune cells which are amplified and activated in vitro. However,due to the complex tumor immunosuppressive microenvironment,immune cells are prone to exhaust and difficult to penetrate deep into the tumor, resulting in limited effect in solid tumors. In recent years,nanomaterials have received extensive attention in the field of tumor immunotherapy. Nanomaterials can promote the expansion of immune cells,their survival after in vivo infusion,and their infiltration in tumors,help immune cells to overcome the physical barriers and immunosuppressive microenvironment in solid tumor tissues,and improve the therapeutic effect. In this article,we reviewed the current research progress of the application of nanomedicine in tumor adoptive cellular immunotherapy.

    Reference
    Related
    Cited by
Get Citation

杨艳,钱汉清,马亚军.纳米药物在肿瘤过继性细胞免疫治疗中的研究进展[J].南京医科大学学报(自然科学版英文版),2023,(10):1441-1449.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 05,2023
  • Revised:
  • Adopted:
  • Online: October 23,2023
  • Published:
Article QR Code